31
In band
Moving averages
SMA 200$4.86-73.66%
Company profile
Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapeutic drugs that modulate the endocannabinoid system. The company is headquartered in San Diego, California.
SectorHealthcare
IndustryBiotechnology
Market cap$5.67M
P/E ratioNone
EPS$-10.16
Beta2.859
Dividend yield0.00%
52-week high$2.25
52-week low$0.26
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
IMNN
Imunon Inc
RSI 36
ACXP
Acurx Pharmaceuticals Inc
RSI 27
SNGX
Soligenix Inc
RSI 48
PHIO
Phio Pharmaceuticals Corp
RSI 37
GOVX
Geovax Labs Inc
RSI 17
VRAX
Virax Biolabs Group Ltd - Class A
RSI 27
RSI alerts for SKYE
An email when SKYE closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 31 October 2026 at 8:38 PM EDT